Dementia

• FDA label_change · 2015-05-04
  FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)

  FDA approved a supplemental application for NEURACEQ (Florbetaben F-18) by Lantheus Biosciences Ltd., expanding its labeling.

• FDA label_change · 2014-10-15
  FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)

  The FDA approved a supplemental application for NEURACEQ (florbetaben F-18), expanding labeling to support its use as a PET imaging agent to…